Cannabidiol for Prevention of Chemotherapy-induced Peripheral Neuropathy
Status:
Recruiting
Trial end date:
2023-08-30
Target enrollment:
Participant gender:
Summary
This protocol describes a phase II trial investigating the efficacy of CBD in paclitaxel- and
oxaliplatin-induced peripheral neuropathy. The trial uses multiple assessments such as
validated PRO-questionnaires and multifrequency vibrometry.